Pharmaceutical composition for treating multiple sclerosis comprising pracinostat
The present invention relates to a pharmaceutical composition for treating multiple sclerosis containing pracinostat. Pracinostat according to the present invention can selectively induce the expression of immunomodulatory enzyme IDO only in inflammatory lesions in a central nervous system, thereby...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Korean |
Published |
04.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition for treating multiple sclerosis containing pracinostat. Pracinostat according to the present invention can selectively induce the expression of immunomodulatory enzyme IDO only in inflammatory lesions in a central nervous system, thereby being able to be usefully used as a novel multiple sclerosis medicine.
본 발명은 프라시노스타트(pracinostat)를 포함하는 다발성 경화증 치료용 약학 조성물에 관한 것이다. 본 발명에 따른 프라시노스타트는 중추신경조직 내 염증병소에서만 선택적으로 면역조절효소 IDO의 발현을 유도하여 염증세포를 제어 할 수 있어 새로운 다발성 경화증 치료제로 유용하게 사용할 수 있다. |
---|---|
Bibliography: | Application Number: KR20180099321 |